Skip to main navigation
Skip to search
Skip to main content
Discovery - the University of Dundee Research Portal Home
Home
Profiles
Research units
Research Outputs
Projects
Datasets
Theses
Activity
Press/Media
Research Facilities
Prizes
Search by expertise, name or affiliation
Long-acting β2-adrenoceptor agonists: a smart choice for asthma?
Brian J. Lipworth
Research output
:
Contribution to journal
›
Article
›
peer-review
30
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Long-acting β2-adrenoceptor agonists: a smart choice for asthma?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Asthma
100%
Adrenoceptor Agonist
100%
β2-adrenoceptor Agonist
100%
Smart Decision
100%
Salmeterol
50%
Adverse Effects
25%
Placebo
25%
Twice Daily
25%
Inhaled Corticosteroids
25%
Pharmacological Properties
25%
Asthma Control
25%
Short-acting
25%
Drug Class
25%
Asthmatic
25%
Asthma Exacerbation
25%
Salbutamol
25%
β2-adrenoceptor
25%
Pharmacological Uses
25%
Beclomethasone
25%
Airway Smooth muscle
25%
Pharmacological Mechanism
25%
Muscle Spasm
25%
Impaired Relaxation
25%
Bronchodilator Therapy
25%
Acute Episodes
25%
Bronchial Smooth muscle
25%
Anti-inflammatory Therapy
25%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
100%
Adrenergic Receptor Stimulating Agent
100%
Beta 2 Adrenergic Receptor Stimulating Agent
100%
Salmeterol
50%
Placebo
25%
Anti-Inflammatory Drug
25%
Salbutamol
25%
Beta 2 Adrenergic Receptor
25%
Beclometasone
25%
Bronchodilating Agent
25%
Smooth Muscle Spasm
25%